FDA approves Actavis' reversible contraceptive device

February 27, 2015 2:52 PM

1 0

The U.S. Food and Drug Administration approved a hormonal contraceptive device on Friday that gives American women another reversible contraceptive choice as effective as sterilization.

Actavis Plc holds the commercial license to the device, Liletta. The marketing application was submitted by non-profit pharmaceutical company Medicines360, which holds the U.S. public sector clinic rights.

Read more

To category page